{
    "title": "Risks of Endo's opioid painkiller outweigh benefits: FDA panel",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-4314138/Risks-Endos-opioid-painkiller-outweigh-benefits-FDA-panel.html",
    "date": "2017-03-14",
    "keywords": [
        "abuse",
        "oxymorphone",
        "market",
        "reformulation",
        "panel",
        "fda",
        "percent",
        "rate",
        "opana",
        "formulation",
        "grovermarch",
        "plcs",
        "painkiller",
        "food",
        "drug",
        "administration",
        "tuesdayendos",
        "tradingopioid",
        "overdose",
        "addiction",
        "prescription",
        "paucity",
        "access",
        "treatment",
        "endos",
        "variation",
        "oxymorphine",
        "er",
        "staff",
        "review",
        "rise",
        "reformulationthis",
        "trend",
        "concern",
        "blood",
        "hiv",
        "tuesdaysince",
        "introduction",
        "number",
        "abusedeterrent",
        "member",
        "question",
        "riskbenefit",
        "profile",
        "user",
        "versus",
        "addictsome",
        "product",
        "addict",
        "part",
        "arsenal",
        "painthe",
        "restrict",
        "andor",
        "theyll",
        "litman",
        "saidi",
        "place",
        "society",
        "today",
        "reporting",
        "grover",
        "bengaluru",
        "editing",
        "maju",
        "samuel",
        "shounak",
        "dasgupta"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}